Xiaoyun Liao, M.D., Ph.D.
About Xiaoyun Liao, M.D., Ph.D.
Xiaoyun Liao, M.D., Ph.D., is the Associate Director at Bristol Myers Squibb with over 20 years of experience in clinical practice, cancer research, and oncology/immuno-oncology translational research.
Current Position at Bristol Myers Squibb
Xiaoyun Liao, M.D., Ph.D., is currently serving as the Associate Director at Bristol Myers Squibb. In this role, Dr. Liao brings a wealth of expertise in clinical and translational research to the organization. She leverages over two decades of experience in oncology and immuno-oncology to lead projects and initiatives aimed at advancing cancer treatment and diagnostics.
Previous Roles in Science and Research
Before joining Bristol Myers Squibb, Dr. Xiaoyun Liao held several significant positions in prominent organizations. From 2018 to 2021, she worked as the Principal Scientist and Pathology Lab Head at Boehringer Ingelheim in the Greater New York City Area. Prior to this, she served as a Senior Scientist II at AbbVie from 2015 to 2018 in the Greater Chicago Area. From 2010 to 2015, Dr. Liao was a Senior Scientist at the Dana-Farber Cancer Institute in Boston. Her foundational career began at Peking University, where she was the Associate Chief Pathologist for 18 years, from 1992 to 2010.
Educational Background and Expertise
Dr. Xiaoyun Liao received her Doctor of Philosophy (Ph.D.) in Molecular Pathology and Cancer Biology from The University of Hong Kong LKS Faculty of Medicine. She also holds an M.D. and a Master's degree in Pathology from Peking University Health Science Center. Additionally, she has completed studies at the Dana-Farber Cancer Institute, further bolstering her extensive knowledge and expertise in the field.
Specialization in Cancer and Translational Research
With over 20 years of combined experience in clinical practice, clinical cancer research, and oncology/immuno-oncology translational research, Dr. Liao is an expert in human anatomic pathology, including clinical diagnosis and research pathology. She specializes in tissue-based tumor biomarkers, such as IHC assay development, validation, and evaluation. Her profound knowledge in these areas has significantly contributed to advancements in cancer diagnostics and treatment.
Skills in Data Analytics and Research Pathology
Dr. Xiaoyun Liao possesses strong data analytics skills, essential for advancing research in the rapidly evolving fields of oncology and immuno-oncology. Her broad knowledge and extensive experience in clinical research, translational research, translational pathology, cancer research, molecular pathology, and immuno-oncology have enabled her to contribute significantly to scientific and medical advancements.